Strychnidin-10-one hydrochloride (1:1)

Suppliers

Names

[ Name ]:
Strychnidin-10-one hydrochloride (1:1)

[Synonym ]:
strychnine*HCl
Strychnin,Hydrochlorid
MFCD00058174
strychnine,monohydrochloride
Strychnidin-10-onehydrochloride
EINECS 215-826-9
Strychnidin-10-one, hydrochloride (1:1)
strychnine,hydrochloride
Strychnidin-10-one hydrochloride (1:1)
Strychnidin-10-one, monohydrochloride (9CI)
strychnidin-10-one,monohydrochloride
Strychnine Hydrochloride Hydrate

Chemical & Physical Properties

[ Boiling Point ]:
559.9ºC at 760mmHg

[ Melting Point ]:
295 °C

[ Molecular Formula ]:
C₂₁H₂₃ClN₂O₂

[ Molecular Weight ]:
370.872

[ Flash Point ]:
292.4ºC

[ Exact Mass ]:
370.144806

[ PSA ]:
32.78000

[ LogP ]:
2.89740

[ Vapour Pressure ]:
1.44E-12mmHg at 25°C

[ Storage condition ]:
Store at RT

MSDS

Click to get detail MSDS

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :: WL2430000

CHEMICAL NAME :: Strychnine, monohydrochloride

CAS REGISTRY NUMBER :: 1421-86-9

LAST UPDATED :: 199106

DATA ITEMS CITED :: 4

MOLECULAR FORMULA :: C21-H22-N2-O2.Cl-H

MOLECULAR WEIGHT :: 370.91

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Subcutaneous

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 2730 ug/kg

TOXIC EFFECTS :: Behavioral - rigidity (including catalepsy)

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intravenous

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 650 ug/kg

TOXIC EFFECTS :: Behavioral - general anesthetic

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Subcutaneous

SPECIES OBSERVED :: Mammal - dog

DOSE/DURATION :: 460 ug/kg

TOXIC EFFECTS :: Lungs, Thorax, or Respiration - dyspnea

MUTATION DATA

TYPE OF TEST :: Gene conversion and mitotic recombination

TEST SYSTEM :: Bacteria - Salmonella typhimurium

DOSE/DURATION :: 3 mmol/L

REFERENCE :: EMMUEG Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- Volume(issue)/page/year: 10,27,1987

Safety Information

[ Symbol ]:

GHS06, GHS09

[ Signal Word ]:
Danger

[ Hazard Statements ]:
H300-H330-H410

[ Precautionary Statements ]:
P260-P264-P273-P284-P301 + P310-P310

[ Personal Protective Equipment ]:
Eyeshields;Faceshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges

[ Hazard Codes ]:
T+: Very toxic;N: Dangerous for the environment;

[ Risk Phrases ]:
R26/27/28

[ Safety Phrases ]:
S22-S36/37/39-S45-S61-S60

[ RIDADR ]:
UN 1692 6.1/PG 1

[ WGK Germany ]:
3

[ RTECS ]:
WL2430000

[ Packaging Group ]:
I

[ Hazard Class ]:
6.1(a)

Articles

Parallel ON and OFF cone bipolar inputs establish spatially coextensive receptive field structure of blue-yellow ganglion cells in primate retina.

J. Mol. Endocrinol. 29 , 8372-87, (2009)

In the primate retina the small bistratified, "blue-yellow" color-opponent ganglion cell receives parallel ON-depolarizing and OFF-hyperpolarizing inputs from short (S)-wavelength sensitive and combin...

Phosphocholine-Modified Macromolecules and Canonical Nicotinic Agonists Inhibit ATP-Induced IL-1β Release.

J. Immunol. 195 , 2325-34, (2015)

IL-1β is a potent proinflammatory cytokine of the innate immune system that is involved in host defense against infection. However, increased production of IL-1β plays a pathogenic role in various inf...

Inhibitory Interneurons That Express GFP in the PrP-GFP Mouse Spinal Cord Are Morphologically Heterogeneous, Innervated by Several Classes of Primary Afferent and Include Lamina I Projection Neurons among Their Postsynaptic Targets.

J. Neurosci. 35 , 7626-42, (2015)

The superficial dorsal horn of the spinal cord contains numerous inhibitory interneurons, which regulate the transmission of information perceived as touch, pain, or itch. Despite the importance of th...

brucine hydrochloride
5-oxo-L-proline, compound with strychnidin-10-one (1:1)
Hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3(4H)-one Hydrochloride
(4aR,5aS,8aR,13aS,15aS)-4a,5,5a,7,8,13a,15,15a,15b,16-decahydro-2H-4,6-methanoindolo[3,2,1-ij]oxepino[2,3,4-de]pyrrolo[2,3-h]quinoline-14-one,arsorous acid
Strychnidin-10-one, compd. with methylarsonate (1:1)
(4aR,5aS,8aR,13aS,15aS,15bR)-4a,5,5a,7,8,13a,15,15a,15b,16-decahydro-2H-4,6-methanoindolo[3,2,1-ij]oxepino[2,3,4-de]pyrrolo[2,3-h]quinoline-14-one,phosphonous acid,dihydrate
5-Fluoro-6-phenylpyridine-3-carbaldehyde
tert-butyl N-[2-chloro-4-(hydroxymethyl)pyridin-3-yl]carbamate
(6-Bromoquinolin-8-yl)methanamine
5-Cyclobutyl-3-(4,4-difluoropyrrolidin-2-yl)-1,2,4-oxadiazole hydrochloride
1-(3-(Fluoromethyl)azetidin-1-yl)-2-(4-(trifluoromethoxy)phenyl)ethanone
N-(1-(benzofuran-2-yl)propan-2-yl)-2-isopropyl-1-methyl-1H-imidazole-4-sulfonamide
(7-(2-Chlorophenyl)-1,1-dioxido-1,4-thiazepan-4-yl)(quinoxalin-2-yl)methanone
N-[(4,6-dimethoxy-1,3,5-triazin-2-yl)methyl]-4-methoxybenzamide
2-(4,5-dimethyl-6-oxopyrimidin-1(6H)-yl)-N-(1-((tetrahydro-2H-pyran-2-yl)methyl)-1H-pyrazol-4-yl)acetamide
2-(2-methoxyethoxy)-N-(2-(pyridin-4-yl)ethyl)isonicotinamide